BIOMAT Database Logo BIOMAT Database Logo

Secondary pulmonary alveolar proteinosis after unrelated cord blood hematopoietic cell transplantation. 2012

Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Department of Pediatrics, Hematology Unit, University Hospital Geneva, Geneva, Switzerland. marc.ansari@hcuge.ch

PAP is a rare alveolointerstitial lung disorder characterized histologically by the intra-alveolar accumulation of eosinophilic and PAS-positive material. We observed two cases of PAP after unrelated CB hematopoietic progenitor cell transplantation in children with ALL. No antagonist activity toward GM-CSF was identified in the patient tested. The putative multifactorial PAP etiology is discussed. This potentially curable condition should be considered in a CB allograft recipient with alveolointerstial lung disorder.

UI MeSH Term Description Entries
D008297 Male Males
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011649 Pulmonary Alveolar Proteinosis A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR. Alveolar Proteinoses, Pulmonary,Alveolar Proteinosis, Pulmonary,Proteinoses, Pulmonary Alveolar,Proteinosis, Pulmonary Alveolar,Pulmonary Alveolar Proteinoses
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. Leukemia, Lymphoblastic,Leukemia, Lymphoid, Acute,Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Lymphocytic Leukemia, Acute,Lymphoma, Lymphoblastic,ALL, Childhood,Acute Lymphoid Leukemia,Leukemia, Acute Lymphoblastic,Leukemia, Lymphoblastic, Acute,Leukemia, Lymphoblastic, Acute, L1,Leukemia, Lymphoblastic, Acute, L2,Leukemia, Lymphoblastic, Acute, Philadelphia-Positive,Leukemia, Lymphocytic, Acute,Leukemia, Lymphocytic, Acute, L1,Leukemia, Lymphocytic, Acute, L2,Lymphoblastic Leukemia, Acute,Lymphoblastic Leukemia, Acute, Adult,Lymphoblastic Leukemia, Acute, Childhood,Lymphoblastic Leukemia, Acute, L1,Lymphoblastic Leukemia, Acute, L2,Lymphocytic Leukemia, L1,Lymphocytic Leukemia, L2,Acute Lymphoblastic Leukemia,Acute Lymphocytic Leukemia,Childhood ALL,L1 Lymphocytic Leukemia,L2 Lymphocytic Leukemia,Leukemia, Acute Lymphocytic,Leukemia, Acute Lymphoid,Leukemia, L1 Lymphocytic,Leukemia, L2 Lymphocytic,Lymphoid Leukemia, Acute,Precursor Cell Lymphoblastic Leukemia Lymphoma
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell

Related Publications

Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Pulmonary alveolar proteinosis following allogeneic hematopoietic cell transplantation.
November 2011, Bone marrow transplantation,
Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Diffuse alveolar hemorrhage after unrelated cord blood transplantation.
April 2010, Bone marrow transplantation,
Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Acquired pulmonary alveolar proteinosis after umbilical cord blood transplantation for acute myeloid leukemia.
June 2002, American journal of hematology,
Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Pulmonary alveolar proteinosis after lung transplantation.
July 2020, Respirology case reports,
Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Secondary pulmonary alveolar proteinosis after lung transplantation: a single-centre series.
February 2017, The European respiratory journal,
Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Allogeneic Hematopoietic Stem Cell Transplantation After Prior Lung Transplantation for Hereditary Pulmonary Alveolar Proteinosis: A Case Report.
January 2022, Frontiers in immunology,
Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Results of unrelated umbilical cord blood hematopoietic stem cell transplantation.
June 2001, Reviews in clinical and experimental hematology,
Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?
June 2003, Blood,
Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Hematopoietic stem cell transplantation for pulmonary alveolar proteinosis associated with primary immunodeficiency disease.
May 2018, International journal of hematology,
Marc Ansari, and Anne-Laure Rougemont, and Françoise Le Deist, and Hulya Ozsahin, and Michel Duval, and Martin A Champagne, and Jean-Christophe Fournet
Nonmyeloablative hematopoietic stem cell transplantation in a patient with hereditary pulmonary alveolar proteinosis.
February 2021, Pediatric pulmonology,
Copied contents to your clipboard!